IIPR Stock Analysis: Innovative Industrial | NYSE

REIT - Industrial | NYSE, USA | Market Cap: 1.509m USD | 12M Return: 22.2% | US45781V1017 | Charts, Fundamentals & Technical Analysis

Industrial REITs, Life Science, Specialized Industrial, Real Estate Trust
Total Rating 62
Safety 45
Buy Signal -0.09
Industrial REITs
Sub-Industry Rotation: +3.3
Market Cap: 1.51B
Avg Turnover: 15.4M
Risk 3d forecast
Volatility41.8%
VaR 5th Pctl6.68%
VaR vs Median-2.51%
Reward TTM
Sharpe Ratio0.62
Rel. Str. IBD65.1
Rel. Str. Peer Group90 pctl
Character TTM
Beta0.261
Beta Downside0.672
Hurst Exponent0.482
Choppyness54.2%
Drawdowns 3y
Max DD62.92%
CAGR/Max DD-0.06
CAGR/Mean DD-0.11
EPS (Earnings per Share) EPS (Earnings per Share) of IIPR over the last years for every Quarter: "2021-09": 1.2, "2021-12": 1.14, "2022-03": 1.32, "2022-06": 1.42, "2022-09": 1.32, "2022-12": 1.33, "2023-03": 1.43, "2023-06": 1.44, "2023-09": 1.45, "2023-12": 1.45, "2024-03": 1.36, "2024-06": 1.44, "2024-09": 1.37, "2024-12": 1.36, "2025-03": 1.03, "2025-06": 0.86, "2025-09": 0.97, "2025-12": 1.06, "2026-03": 1.04, "2026-06": 1.83, "2026-09": 1.96,
EPS CAGR: -8.65%
EPS Trend: -53.1%
Last SUE: 3.38
Qual. Beats: 2
Revenue Revenue of IIPR over the last years for every Quarter: 2021-09: 53.856, 2021-12: 58.943, 2022-03: 64.504, 2022-06: 70.511, 2022-09: 70.883, 2022-12: 70.461, 2023-03: 76.067, 2023-06: 76.457, 2023-09: 77.826, 2023-12: 79.156, 2024-03: 75.454, 2024-06: 79.793, 2024-09: 76.526, 2024-12: 76.744, 2025-03: 71.722, 2025-06: 62.891, 2025-09: 64.685, 2025-12: 66.657, 2026-03: 68.996, 2026-06: 63.315, 2026-09: 64.92,
Rev. CAGR: -7.46%
Rev. Trend: -93.1%
Last SUE: 1.49
Qual. Beats: 1

Warnings

Below Avwap Earnings
Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality 9.9 years of data, until 10/2026

Jan -0.8% 4
Feb +0.1% 4
Mar -0.4% 4
Apr +0.2% 4
May +0.5% 4
Jun +2.9% 15
Jul +1.6% 0
Aug +5.5% 4
Sep -1.7% 4
Oct -5.9% 15
Nov -0.4% 0
Dec -1.2% 0

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, ≥40 worth a closer look and ≥60 is strong.

Description: IIPR Innovative Industrial

Innovative Industrial Properties, Inc. (IIPR) is an internally managed real estate investment trust (REIT) that acquires, owns, and manages specialized industrial properties and related financial investments serving the life sciences industry. As of June 30, 2026, the company held 108 properties totaling approximately 8.4 million rentable square feet across 19 U.S. states, and was established on June 15, 2016 as a Maryland-incorporated entity listed on the NYSE.

IIPR operates within the Industrial REITs sub-industry and is recognized for focusing on sale-leaseback and triple-net lease structures with state-licensed cannabis operators, making it one of the few public REITs with material exposure to the U.S. regulated cannabis sector. As a REIT under U.S. tax law, the company is generally required to distribute the majority of its taxable income to shareholders in the form of dividends.

Headlines to Watch Out For
  • Cannabis tenant rent collections face regulatory uncertainty
  • Triple-net lease escalators drive same-property revenue growth
  • Capital allocation focuses on portfolio diversification beyond core cannabis holdings
Piotroski VR-10 (Strict) 4.5
Net Income: 140.4m TTM > 0 and > 6% of Revenue
FCF/TA: 0.07 > 0.02 and ΔFCF/TA -0.62 > 1.0
NWC/Revenue: 12.91% < 20% (prev -5.73%; Δ 18.64% < -1%)
CFO/TA 0.08 > 3% & CFO 200.3m > Net Income 140.4m
Net Debt (554.6m) to EBITDA (249.2m): 2.23 < 3
Current Ratio: 1.31 > 1.5 & < 3
Outstanding Shares: last quarter (28.0m) vs 12m ago -1.21% < -2%
Gross Margin: 60.61% > 18% (prev 89.20%; Δ -28.59% > 0.5%)
Asset Turnover: 10.58% > 50% (prev 11.81%; Δ -1.23% > 0%)
Interest Coverage Ratio: 5.21 > 6 (EBIT TTM 173.7m / Interest Expense TTM 33.3m)
Altman Z'' 2.44
A: 0.01 (Total Current Assets 145.3m - Total Current Liabilities 111.2m) / Total Assets 2.65b
B: -0.14 (Retained Earnings -374.2m / Total Assets 2.65b)
C: 0.07 (EBIT TTM 173.7m / Avg Total Assets 2.49b)
D: 2.23 (Book Value of Equity 1.83b / Total Liabilities 820.2m)
Altman-Z'' = 2.44 = A
What is the price of IIPR shares?

As of November 18, 2026, the stock is trading at USD 50.50 with a total of 404,180 shares traded. Over the past week, the price has changed by -8.28%, over one month by -2.15%, over three months by -6.23% and over the past year by +22.22%.

Current recommended Stop Loss: 48.60 (which is 3.8% or 1.3 ATR below the current price).

Is IIPR a buy, sell or hold?

Innovative Industrial has received a consensus analysts rating of 3.43. Therefore, it is recommended to hold IIPR.

  • StrongBuy: 2
  • Buy: 0
  • Hold: 4
  • Sell: 1
  • StrongSell: 0

What are the forecasts/targets for the IIPR price?
Analysts Target Price 63.4 25.4%
Innovative Industrial (IIPR) - Fundamental Data Overview as of 13 November 2026
Market Cap USD = 1.51b (1.51b USD * 1.0 USD.USD)
P/E Trailing = 12.3288
P/E Forward = 12.3457
P/S = 5.7192
P/B = 0.8922
Revenue TTM = 263.9m USD
EBIT TTM = 173.7m USD
EBITDA TTM = 249.2m USD
Long Term Debt = 508.5m USD (from longTermDebt, last quarter)
Short Term Debt = 187.5m USD (from shortLongTermDebt, last quarter)
Debt = 697.0m USD (from shortLongTermDebtTotal, last quarter) + Leases 998k
Net Debt = 554.6m USD (calculated: Debt 697.0m - CCE 142.4m)
Enterprise Value = 2.06b USD (1.51b + Debt 697.0m - CCE 142.4m)
Interest Coverage Ratio = 5.21 (Ebit TTM 173.7m / Interest Expense TTM 33.3m)
EV/FCF = 10.43x (Enterprise Value 2.06b / FCF TTM 197.9m)
FCF Yield = 9.59% (FCF TTM 197.9m / Enterprise Value 2.06b)
FCF Margin = 74.98% (FCF TTM 197.9m / Revenue TTM 263.9m)
Net Margin = 53.20% (Net Income TTM 140.4m / Revenue TTM 263.9m)
Gross Margin = 60.61% ((Revenue TTM 263.9m - Cost of Revenue TTM 103.9m) / Revenue TTM)
Gross Margin QoQ = 89.31% (prev 88.63%)
Tobins Q-Ratio = 0.78 (Enterprise Value 2.06b / Total Assets 2.65b)
Interest Expense / Debt = 4.78% (Interest Expense 33.3m / Debt 697.0m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = 137.2m (EBIT 173.7m * (1 - 21.00%))
Current Ratio = 1.31 (Total Current Assets 145.3m / Total Current Liabilities 111.2m)
Debt / Equity = 0.38 (Debt 697.0m / totalStockholderEquity, last quarter 1.83b)
Debt / EBITDA = 2.23 (Net Debt 554.6m / EBITDA 249.2m)
Debt / FCF = 2.80 (Net Debt 554.6m / FCF TTM 197.9m)
Total Stockholder Equity = 1.86b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.63% (Net Income 140.4m / Total Assets 2.65b)
RoE = 7.56% (Net Income TTM 140.4m / Total Stockholder Equity 1.86b)
RoCE = 7.35% (EBIT 173.7m / Capital Employed (Equity 1.86b + L.T.Debt 508.5m))
RoIC = 4.82% (NOPAT 137.2m / Invested Capital 2.85b)
WACC = 5.65% (E(1.51b)/V(2.21b) * Re(6.52%) + D(697.0m)/V(2.21b) * Rd(4.78%) * (1-Tc(0.21)))
Discount Rate = 6.52% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 10.53 | Cagr: -0.96%
[DCF] Terminal Value 76.05% ; FCFF base≈194.3m ; Y1≈202.8m ; Y5≈232.0m
[DCF] Fair Price = 109.7 (EV 3.58b - Net Debt 554.6m = Equity 3.03b / Shares 27.6m; r=8.35% [WACC [floored]]; 5y FCF grow 4.74% → 2.50% )
EPS Correlation: -53.12 | EPS CAGR: -8.65% | SUE: 3.38 | # QB: 2
Revenue Correlation: -93.14 | Revenue CAGR: -7.46% | SUE: 1.49 | # QB: 1
EPS current Year (2026-12-31): EPS=4.15 | Chg30d=-3.04% | Revisions=-25% | GrowthEPS=+5.6% | GrowthRev=-3.8%
EPS next Year (2027-12-31): EPS=4.39 | Chg30d=-8.35% | Revisions=+0% | GrowthEPS=+5.8% | GrowthRev=-2.9%